| | | | | | | |
 | REGENERON PHARMACEUTICALS, INC. | -1.40% | 1.51% | 6.72% | 23.71% | 101.62% | 82 172 |
| VERTEX PHARMACEUTICALS | 1.20% | -4.72% | 6.84% | 26.84% | 28.53% | 79 200 |
 | WUXI APPTEC CO., LTD. | 0.28% | -2.32% | 13.21% | -12.25% | 50.47% | 39 533 |
| BIONTECH SE | 0.82% | 0.33% | -5.40% | -17.76% | 360.22% | 34 537 |
| BEIGENE, LTD. | 1.61% | -2.69% | 13.27% | 13.84% | 51.01% | 25 942 |
 | GENMAB A/S | 0.93% | 0.97% | -7.41% | 23.21% | 65.53% | 25 345 |
 | ARGENX SE | 0.78% | 0.29% | 0.69% | 41.53% | 143.04% | 20 637 |
| SAREPTA THERAPEUTICS, INC. | 2.50% | -3.34% | -6.78% | 59.04% | 1.97% | 10 603 |
| NEUROCRINE BIOSCIENCES, INC. | -1.14% | -3.02% | -13.08% | 28.14% | -0.15% | 9 981 |
| LEGEND BIOTECH CORPORATION | 1.99% | 0.30% | 1.46% | 19.09% | --.--% | 8 479 |
| HALOZYME THERAPEUTICS, INC. | -0.33% | -0.19% | -9.19% | 50.77% | 162.35% | 6 986 |
| KARUNA THERAPEUTICS, INC. | 1.84% | -1.46% | -0.41% | 77.74% | 111.81% | 6 724 |
| ASCENDIS PHARMA A/S | 1.93% | -5.50% | -4.73% | -3.84% | -18.92% | 6 515 |
 | REMEGEN CO., LTD. | -1.02% | 1.03% | 8.81% | 24.51% | --.--% | 6 116 |
| EXELIXIS, INC. | 0.12% | -1.87% | 7.79% | -9.48% | -9.10% | 5 577 |
| | | | | | | |
| | Promedio | 0.67% | -1.38% | 0.79% | 23.01% | 80.64% | |
| | Media ponderada por Capi. | 0.41% | -1.31% | 3.83% | 18.46% | 92.48% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Reporte
